Tumour Budding/T-cell infiltrates in Colorectal Cancer: Proposal of a Novel Combined Score.

Dawson, Heather; Christe, Lucine; Eichmann, Micha; Reinhard, Stefan; Zlobec, Inti; Blank, Annika; Lugli, Alessandro (2020). Tumour Budding/T-cell infiltrates in Colorectal Cancer: Proposal of a Novel Combined Score. Histopathology, 76(4), pp. 572-580. Wiley 10.1111/his.14006

Preview

Text Dawson_et_al-2019-Histopathology.pdf - Accepted Version Available under License Publisher holds Copyright. Download (25MB) | Preview

AIMS

The TNM classification system is used for prognostication purposes and to guide patient management. However, in colorectal cancer (CRC), additional markers are needed to stratify prognostic subgroups. From large bodies of research, two promising markers have emerged: Tumour budding and T-cell host response (CD3, CD8 and CD45RO infiltrates). However, attempts to combine these two parameters have been sparse. The aim of this study was to perform an assessment of potential protagonists that could be used in a combined score (Budding/T-cell Score, BTS).

METHODS AND RESULTS

This descriptive, retrospective study was performed on a multi-punch tissue microarray containing material from 345 patients with Stage I-IV CRC. Areas from tumour centre, front and microenvironment were stained for Pancytokeratin/CD3, Pancytokeratin/CD8 and Pancytokeratin/CD45RO. Tumour buds were scored manually and T-cell infiltrates digitally using open-source software (QuPath). Tumour buds, T-cell counts and combined BTS were associated with clinico-pathological features and overall survival (OS). A higher combined BTS score (Buds/CD8, tumour centre) performed better than budding or CD8/CD3 alone in predicting nodal metastases (p<0.0001, OR 1.466, 95%CI: 1.115-1.928). Only higher BTS (Buds/CD3) was significantly associated with poorer OS on multivariate analysis (p= 0.012, HR 1.218, 95%CI: 1.044-1.419).

CONCLUSIONS

Although CD8+/CD3+ T-cells are predictive of tumour biology in CRC, we found a combined BTS to be stronger in predicting survival and certain features with high clinical relevance, such as nodal metastases, in comparison to budding or T-cells alone. Further studies combining T-cell infiltrates and tumour budding are necessary to optimize risk assessment of CRC.

Interest & Impact

Downloads

343 since deposited on 21 Nov 2019
63 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item